Dr. Bauer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
450 Brookline Ave
Boston, MA 02215Phone+1 617-632-3000Fax+1 617-632-4773- Is this information wrong?
Education & Training
- Children's Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 2008 - 2012
- Children's Hospital/Boston Medical CenterResidency, Pediatrics, 2006 - 2008
- Perelman School of Medicine at the University of PennsylvaniaClass of 2006
Certifications & Licensure
- MA State Medical License 2008 - 2025
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- Improving prime editing with an endogenous small RNA-binding protein.Jun Yan, Paul Oyler-Castrillo, Purnima Ravisankar, Carl C Ward, Sébastien Levesque, Yangwode Jing, Danny Simpson, Anqi Zhao, Hui Li, Weihao Yan, Laine Goudy, Ralf Schm...> ;Nature. 2024 Apr 3
- 12 citationsEpitope editing enables targeted immunotherapy of acute myeloid leukaemia.Gabriele Casirati, Andrea Cosentino, Adele Mucci, Mohammed Salah Mahmoud, Iratxe Ugarte Zabala, Jing Zeng, Scott B Ficarro, Denise Klatt, Christian Brendel, Alessandro...> ;Nature. 2023 Sep 1
- 1 citationsRUNX1 mutations mitigate quiescence to promote transformation of hematopoietic progenitors in Fanconi anemia.William Marion, Tiago Koppe, Chun-Chin Chen, Dahai Wang, Katie Frenis, Sara Fierstein, Prerana Sensharma, Olivia Aumais, Michael Peters, Sonya Ruiz-Torres, Tafadzwa Ch...> ;Leukemia. 2023 Aug 1
- Join now to see all
Journal Articles
- CRISPRO: Identification of Functional Protein Coding Sequences Based on Genome Editing Dense MutagenesisDaniel Bauer, MD, BioMed Central
Abstracts/Posters
- CRISPR-Cas9 Screen Identifies XPO7 As a Potential Therapeutic Target for TP53-Mutated AMLDaniel E. Bauer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Durable and Robust Fetal Globin Induction without Anemia in Rhesus Monkeys Following Autologous Hematopoietic Stem Cell Transplant with BCL11A Erythroid Enhancer EditingDaniel E. Bauer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Therapeutic Base Editing of Human Hematopoietic Stem CellsDaniel E. Bauer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Lectures
- Transcriptional Signaling Centers Govern Human Erythropoiesis and Harbor Genetic Variations of Red Blood Cell Traits2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Opportunities for Scientists in Hematology: Nothing Basic About Discovery60th American Society of Hematology Annual Meeting - 11/30/2018
Press Mentions
- Boston Woman Adopts 3 Girls That Have Same Incurable Blood Disease She Has: ‘It’s a Miracle We Found Each Other’June 12th, 2017
- FDA Poised to Approve First Gene-Editing Therapy, Made by Local Drug FirmsDecember 4th, 2023
- Patients with Sickle Cell Disease Urge FDA to Greenlight Landmark Gene-Editing TreatmentNovember 2nd, 2023
- Join now to see all
Hospital Affiliations
- Dana-Farber Cancer InstituteBoston, Massachusetts
- Boston Children's HospitalBoston, Massachusetts
- Brigham and Women's HospitalBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: